University Hospital of North Norway, Tromsø
Welcome,         Profile    Billing    Logout  
 2 Trials 
14 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Steffensen, Linn H
OVERLORD-MS, NCT04578639 / 2020-001205-23: Ocrelizumab VErsus Rituximab Off-Label at the Onset of Relapsing MS Disease

Active, not recruiting
3
214
Europe
Rituximab, mabthera, Ocrelizumab, ocrevus
Haukeland University Hospital, University Hospital, Akershus, Oslo University Hospital, Helse Stavanger HF, St. Olavs Hospital, University Hospital of North Norway
Relapsing Remitting Multiple Sclerosis
05/25
05/25
NCT06485336: Prophylactic Treatment With Atorvastatin for Chronic Migraine (ChronicStatinMig)

Recruiting
2
300
Europe
Atorvastatin 40mg, Lipitor, Placebo
St. Olavs Hospital, Haukeland University Hospital, Oslo University Hospital, University Hospital of North Norway, University Hospital, Akershus, Ullevaal University Hospital
Chronic Migraine
12/28
02/29
EStatinMig, NCT06248671: Prophylactic Treatment With Atorvastatin for Episodic Migraine.

Recruiting
2
450
Europe
Atorvastatin 40mg, Lipitor, Placebo, Atorvastatin 20mg
St. Olavs Hospital, Haukeland University Hospital, Oslo University Hospital, University Hospital of North Norway, University Hospital, Akershus, Ullevaal University Hospital
Episodic Migraine
12/28
02/29
SMART-MS, NCT04749667: Study of Mesenchymal Autologous Stem Cells as Regenerative Treatment for Multiple Sclerosis

Active, not recruiting
1/2
18
Europe
MSCs, Mesenchymal stem cells, Saline
Haukeland University Hospital, University of Bergen, University Hospital Ulm, University Hospital, Akershus, St. Olavs Hospital, University Hospital of North Norway
Multiple Sclerosis, Progressive Multiple Sclerosis
10/24
01/25
NeuroCovid, NCT04576351: The Norwegian Study of Nervous System Manifestations and Sequelae After COVID-19

Completed
N/A
175
Europe
Observation
Oslo University Hospital, University Hospital, Akershus, Haukeland University Hospital, Helse Stavanger HF, St. Olavs Hospital, University Hospital of North Norway, Vestre Viken Hospital Trust, Sykehuset Telemark, Sykehuset Innlandet HF, Ostfold Hospital Trust, The Hospital of Vestfold, Sorlandet Hospital HF, Nordlandssykehuset HF, Møre og Romsdal Hospital Trust
Covid19
05/23
12/23
Eltoft, Agnethe
TWIST, NCT03181360 / 2014-000096-80: Tenecteplase in Wake-up Ischaemic Stroke Trial

Recruiting
3
600
Europe, US, RoW
Tenecteplase, Metalyse, Control
University Hospital of North Norway, UiT The Arctic University of Norway, The Royal Norwegian Ministry of Health, Norwegian Health Association
Ischemic Stroke, Stroke, Acute
12/21
12/22
ESCAPE-NEXT, NCT04462536 / 2020-002360-30: Efficacy and Safety of Nerinetide in Participants With Acute Ischemic Stroke Undergoing Endovascular Thrombectomy Excluding Thrombolysis

Completed
3
850
Europe, Canada, US, RoW
Placebo, Nerinetide, NA-1
NoNO Inc., University of Calgary
Stroke, Acute
08/23
08/23
GAIN, NCT05119387: Genetic Study of Amyotrophic Lateral Sclerosis in Norway

Recruiting
N/A
1200
Europe
Observation
Sykehuset Telemark, ALS Norge, Helse Sor-Ost
Amyotrophic Lateral Sclerosis
12/30
12/35
NCT05903898: Improving Stroke Care in North-Norway Through Artificial Intelligence

Recruiting
N/A
1000
Europe
AI software StrokeSens (Circle NVI)
University Hospital of North Norway, Nordlandssykehuset HF, Helgelandssykehuset HF, Finnmarkssykehuset HF, Oslo University Hospital
Ischemic Stroke
12/24
12/30
ALS-LTMV, NCT05744310: Effects of Long Term Ventilation Support on the Quality of Life of ALS Patients and Their Families

Recruiting
N/A
200
Europe
Long term mechanical ventilation support, No long term mechanical ventilation support
Haukeland University Hospital, Oslo University Hospital, University Hospital, Akershus, St. Olavs Hospital, Helse Stavanger HF, University Hospital of North Norway
Amyotrophic Lateral Sclerosis, Motor Neuron Disease, Nervous System Diseases, Spinal Cord Diseases, Neurodegenerative Diseases, TDP-43 Proteinopathies
08/32
08/32
Bugge, Einar
TWIST, NCT03181360 / 2014-000096-80: Tenecteplase in Wake-up Ischaemic Stroke Trial

Recruiting
3
600
Europe, US, RoW
Tenecteplase, Metalyse, Control
University Hospital of North Norway, UiT The Arctic University of Norway, The Royal Norwegian Ministry of Health, Norwegian Health Association
Ischemic Stroke, Stroke, Acute
12/21
12/22
Johnsen, Stein-Harald
TenCRAO, NCT04526951: TENecteplase in Central Retinal Artery Occlusion Stuy (S)

Recruiting
3
78
Europe, RoW
Intravenous injection of Tenecteplase and one dose of placebo tablet, Metalyse, One tablet of Acetylsalicylic Acid and one dose of IV placebo, Aspirin
Oslo University Hospital
Central Retinal Artery Occlusion
03/25
03/25
Bjordal, Oddbjorn
TenCRAO, NCT04526951: TENecteplase in Central Retinal Artery Occlusion Stuy (S)

Recruiting
3
78
Europe, RoW
Intravenous injection of Tenecteplase and one dose of placebo tablet, Metalyse, One tablet of Acetylsalicylic Acid and one dose of IV placebo, Aspirin
Oslo University Hospital
Central Retinal Artery Occlusion
03/25
03/25
Bekkeseth, Hanna Marie O
TenCRAO, NCT04526951: TENecteplase in Central Retinal Artery Occlusion Stuy (S)

Recruiting
3
78
Europe, RoW
Intravenous injection of Tenecteplase and one dose of placebo tablet, Metalyse, One tablet of Acetylsalicylic Acid and one dose of IV placebo, Aspirin
Oslo University Hospital
Central Retinal Artery Occlusion
03/25
03/25

Download Options